Abstracts
Showing 14 abstracts.
PROFICIENCY TESTING SUPPORTS COMBINED ANALYSIS OF DOLUTEGRAVIR PHARMACOKINETIC DATA
Conference
CROI 2019
Study
P1093
Authors
N van Ewijk, C Taylor, P Bollen, T Ruane, A Colbers, A Turkova, R Di Francesco, G Morse, R Browne, D Burger, E AcostaDolutegravir pharmacokinetics, safety and efficacy in HIV+ children 2 to <6 years old
Conference
CROI 2017
Study
P1093
Authors
RP Singh, C Alvero, K George, S Popson, C Vavro, R Hazra, A Wiznia, T Ruel, E AcostaGenotypic and Phenotypic Dolutegravir Resistance in Pregnant Women and Children Living with HIV-1
Conference
International Workshop on HIV Drug Resistance and Treatment Strategies
Study
IMPAACT 2010, P1093
Authors
TD Ruel, A Wiznia, S Lockman, L Chinula, PK Drain, GS Gottlieb, LM Frenkel, CL Boyce, RA Smith, R Nixon, MD Bishop, SM Styrchak, K Knowles, S BrummelA Single Once Daily ABC/DTG/3TC Tablet Predicts Safe and Effective Exposures in Children 3 to <6 kg
Conference
CROI 2024
Study
P1093, IMPAACT 2019